Xeltis
Netherlands - Eindhoven
BiotechnologyFocus: Tissue Engineering
Xeltis is a life sciences company focused on Tissue Engineering.
CardiovascularNephrologyWomen's Health
Funding Stage
PUBLIC
Open Jobs
3
Products & Portfolio (2)
2 discontinued products not shown
Pipeline & Clinical Trials
aXess-E conduit
End Stage Renal DiseaseClinical Trials (1)
NCT06329310Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
N/AXeltis Hemodialysis Access
End Stage Renal DiseaseClinical Trials (1)
NCT06494631Xeltis Hemodialysis Access Graft (aXess) US Study
N/AXeltis Bioabsorbable Pulmonary Valved Conduit
Heart Defect, CongenitalClinical Trials (1)
NCT03022708Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
N/AXeltis Vascular Patch, Model COR-VP-001
Heart Defects, CongenitalXeltis Pulmonary Valved Conduit
Heart Defects, CongenitalClinical Trials (1)
NCT03405636Xeltis Pulmonary Valved Conduit Safety and Performance Study
N/AN/A
Clinical Trials (1)
NCT04898153First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft
N/AVascular Graft, Model COR-VG-001
Heart Defects, CongenitalClinical Trials (1)
NCT02377674Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection
N/AClinical Trials (1)
NCT04545112Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)
N/AXeltis Hemodialysis Access
End-stage Renal DiseaseClinical Trials (1)
NCT05473299Xeltis Hemodialysis Access Graft: aXess Pivotal Study
N/ABioabsorbable Pulmonary Valved Conduit
Congenital Heart DiseaseClinical Trials (1)
NCT02700100Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction
N/AXeltis Peripheral Artery Disease
Peripheral Artery Occlusive DiseaseClinical Trials (1)
NCT06951685Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study
N/AOpen Jobs (3)
Interview Prep Quick Facts
Founded: 2016
Portfolio: 4 approved products, 10 clinical trials
Open Roles: 3 active jobs
Portfolio Health
Peak3 (75%)
LOE Approaching1 (25%)
4 total products
Hiring Trend
Stable
3
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles